QualityStocksNewsBreaks Archives - Page 1027 of 1497

WednesdayApr 01, 2020 10:59 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Financial Results for Full-Year 2019

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today released financial results for its full year ended December 31, 2019, as well as select corporate highlights. Among the highlights, the company reported its securing of a $15.0 million equity line with Oasis Capital, LLC, as well as its new subsidiary, Helomics, reaching milestone sequencing tumor cases in partnership with UPMC Magee. “2019 was not without its challenges for the entire healthcare technology industry, yet we continued to execute on our business model, making a synergistic acquisition and shoring up…

WednesdayApr 01, 2020 10:54 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Agreement with FLIR Systems Inc. (NASDAQ: FLIR) to Develop, Market and Distribute QuadSight(R) Vision System

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced its entry into an agreement with FLIR Systems Inc. (NASDAQ: FLIR), the world’s largest and leading commercial company specializing in the design and production of thermal imaging cameras, components and sensors. Under the agreement, the parties will establish a strategic cooperation plan for the development, marketing and distribution of Foresight’s QuadSight(R) vision system, combined with FLIR Systems’ infrared cameras, to a wide range of prospective customers. Foresight will exclusively purchase its thermal cameras from FLIR for all systems to be commercialized worldwide as part of…

WednesdayApr 01, 2020 10:10 am

QualityStocksNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integra Pharma Solutions Files for FDA Emergency Use Authorization for Rapid COVID-19 Test Kit

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that its wholly-owned subsidiary, Integra Pharma Solutions, has filed for an Emergency Use Authorization (“EUA”) with the U.S. Food and Drug Administration (“FDA”) in collaboration with its partnered manufacturer of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit. Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA Commissioner may, in an emergency, allow unapproved medical products or unapproved uses of approved medical products to be used in the diagnosis, treatment or prevention of serious or life-threatening diseases or when there…

WednesdayApr 01, 2020 10:00 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Launch of Next Generation Line of Uniden Cellular Signal Boosters as Millions Migrate to Home Workspaces

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its launch of the next generation line of Uniden(R) cellular signal boosters, helping families and businesses improve network connectivity for work, school and entertainment purposes. According to the update, the new home office line of cellular signal boosters, including the Uniden(R) U60C 4G and Uniden(R) U65C 4G, are designed to improve connectivity, especially as millions of workers migrate from office buildings to home workspaces during the Covid-19 crisis. “Millions of homes and businesses in North America suffer from weak cellular signals, resulting in missed calls, dropped calls and slow data speeds. This…

WednesdayApr 01, 2020 9:24 am

QualityStocksNewsBreaks – MCTC Holdings, Inc. (MCTC) Announces Full Integration of Lelantos Biotech’s Unique Technologies

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, this morning announced the full integration of Lelantos Biotech into MCTC. The company also provided an operational and product introduction update. MCTC announced the acquisition of Lelantos Biotech, Inc. in mid-February. Lelantos Biotech had previously been involved in various areas of cannabinoid and hemp infusion research and had closely collaborated with MCTC in relation to the filing of several patents in numerous hemp extract and cannabinoid delivery technologies. All the developments generated from this collaboration have been assigned to MCTC, and the rights…

TuesdayMar 31, 2020 12:35 pm

QualityStocksNewsBreaks – Jerrick Media Holdings Inc. (JMDA) Announces Timely Filing of 10-K, Strong Finish to 2019

Jerrick Media Holdings (OTCQB: JMDA) today announced the timely filing of its 10-K for the fiscal year ended December 31, 2019. “We had a strong finish to 2019. Development-wise, this year saw a series of significant reinforcements to the foundation of our company's flagship platform, Vocal,” Jerrick CEO Jeremy Frommer stated in the news release. “Product improvements for an enhanced content creation experience as well as systems and compliance updates have been of primary importance. Additionally, Vocal's creative community now benefits from the Vocal+ premium membership program. The company's Vocal for Brands offering continued to expand its client base, with…

TuesdayMar 31, 2020 12:05 pm

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Announces Launch of PrintRite3D Production Series

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced its launch of the Printrite3D(R) Production Series that introduces the “Production Dashboard” and provides production managers with critical metrics, insight and actionable information during the production process. According to the update, the launch comes at a time when many predict a dramatic increase in the use of 3D printing of metal parts in response to COVID-19 and the effect of the pandemic on U.S. manufacturing, especially with manufacturers that rely on complex and lengthy supply chains. More agile and rapid in…

TuesdayMar 31, 2020 12:03 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Helomics’ Continued Progress Toward Developing AI-Driven Predictive Model of Ovarian Cancer

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced continued progress by its Helomics subsidiary toward the goal of developing an AI-driven predictive model of ovarian cancer (CancerQuest 2020). Per the update, CancerQuest2020 (CCQ2020) is focused on building an AI-driven model of ovarian cancer that will predict drug response and outcome. Predictive models embody the knowledge from these profiles, creating a “computational expert” or a “virtual patient” that can be queried. “Despite some headwinds imposed by the current COVID-19 pandemic, the Helomics team has been working diligently to…

TuesdayMar 31, 2020 11:40 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Reports Q4, Full Year 2019 Financial Results

SinglePoint (OTCQB: SING) today reported audited financial results for the three and twelve months ended December 31, 2019. Among other highlights, the company reported total sales of $3,343,833 for the year ended December 31, 2019, representing an increase of 189% year-over-year when compared to total sales of $1,154,671 in 2018. Per the news release, the company attributes the substantial increase to the acquisition of Direct Solar in May 2019. Looking forward, SinglePoint intends to continue to find accretive ways to work with investing partners to improve the company’s balance sheet by strategically removing outstanding notes. “The positive operational results in…

TuesdayMar 31, 2020 11:25 am

QualityStocksNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Provides Update on COVID-19 Impact

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, commercial hemp enterprise and multi-channel lifestyle company, today provided an update on the impact of the COVID-19 virus on its operations. According to the update, all of Youngevity’s three reporting segments have been able to continue operations, as each falls into the category of an essential business. Although Youngevity continues to generate revenue in all segments, it has experienced difficulty in meeting its filing deadline for its Annual Report on Form 10-K for the year ended December 31, 2019, due…

Site Search

Company Search

Category: QualityStocksNewsBreaks